Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

SYDNEY (Reuters) - Australia's Sigma Healthcare shareholders approved in a vote on Wednesday a merger with Chemist Warehouse ...

Eli Lilly and Company (NYSE:LLY), a leading global pharmaceutical firm, finds itself at a pivotal juncture as it navigates a ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...